Advanced Enzyme

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE837H01020
  • NSEID: ADVENZYMES
  • BSEID: 540025
INR
291.30
-5.05 (-1.7%)
BSENSE

Nov 20

BSE+NSE Vol: 1.95 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 1000007,
    "name": "Advanced Enzyme",
    "stock_name": "Advanced Enzyme",
    "full_name": "Advanced Enzyme Technologies Ltd",
    "name_url": "stocks-analysis/advanced-enzyme",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "291.30",
    "chg": -5.05,
    "chgp": "-1.7%",
    "dir": -1,
    "prev_price": "296.35",
    "mcapval": "3,222.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 540025,
    "symbol": "ADVENZYMES",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 11,
    "indexname": "",
    "isin": "INE837H01020",
    "curr_date": "Nov 20",
    "curr_time": "",
    "bse_nse_vol": "1.95 lacs",
    "exc_status": "Active",
    "traded_date": "Nov 20, 2026",
    "traded_date_str": "2026 11 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/advanced-enzyme-1000007-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Advanced Enzyme Technologies Ltd: Valuation Shifts Signal Heightened Price Risk",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/advanced-enzyme-technologies-ltd-valuation-shifts-signal-heightened-price-risk-4268694",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/AdvancedEnzymeT_valuationdot_4268694.png",
        "date": "2026-11-20 08:00:40",
        "description": "Advanced Enzyme Technologies Ltd has seen a marked shift in its valuation parameters, moving from an expensive to a very expensive rating. This change, coupled with its current price movements and relative performance against benchmarks, raises important questions about its price attractiveness and investment appeal in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Advanced Enzyme Technologies Ltd is Rated Sell",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/advanced-enzyme-technologies-ltd-is-rated-sell-4260595",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/AdvancedEnzymeT_mojoScore_4260595.png",
        "date": "2026-11-13 10:11:34",
        "description": "Advanced Enzyme Technologies Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 25 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 13 November 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Advanced Enzyme Technologies Gains 6.56%: 4 Key Factors Driving the Week",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/advanced-enzyme-technologies-gains-656-4-key-factors-driving-the-week-4255299",
        "imagepath": "",
        "date": "2026-11-07 14:02:15",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>2 Nov:</strong> Intraday high surge of 7.57% to Rs.283.60</p>\n                    <p><strong>2 Nov:</strong> Strong quarterly financial results reported</p>\n                    <p><strong>6 Nov:</strong> Technical momentum shifts to mildly bearish</p>\n                    <p><strong>6 Nov:</strong> Valuation reclassified as very expensive</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.262.95</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.280.20</div><div class=\"stat-change positiv..."
      },
      {
        "title": "Advanced Enzyme Technologies Ltd Surges 7.57% to Day's High of Rs 283.6 — Outperforms Sector by 6.95 Percentage Points",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/advanced-enzyme-technologies-ltd-hits-intraday-high-with-757-surge-4247798",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/AdvancedEnzymeT_priceRelatedfactors_4247798.png",
        "date": "2026-11-02 13:31:26",
        "description": "The Sensex advanced 0.86% on 2 Nov 2026, yet Advanced Enzyme Technologies Ltd outpaced the broader market with a robust 7.57% gain, reaching an intraday peak of Rs 283.6. This 6.95 percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers signals a distinctly stock-specific rally rather than a mere market tailwind."
      },
      {
        "title": "Advanced Enzyme Technologies Ltd Reports Strong Quarterly Upswing Amid Positive Financial Trend",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/advanced-enzyme-technologies-ltd-reports-strong-quarterly-upswing-amid-positive-financial-trend-4247706",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/AdvancedEnzymeT_fintrenddot_4247706.png",
        "date": "2026-11-02 12:00:09",
        "description": "Advanced Enzyme Technologies Ltd has demonstrated a marked improvement in its financial performance for the quarter ended September 2026, signalling a positive shift from a previously flat trend. The company recorded its highest quarterly net sales and profitability metrics in recent history, reflecting robust operational execution within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Advanced Enzyme Technologies Ltd is Rated Sell",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/advanced-enzyme-technologies-ltd-is-rated-sell-4247303",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/AdvancedEnzymeT_mojoScore_4247303.png",
        "date": "2026-11-02 10:10:25",
        "description": "Advanced Enzyme Technologies Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 25 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 02 November 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Advanced Enzyme Technologies Ltd is Rated Sell",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/advanced-enzyme-technologies-ltd-is-rated-sell-4233446",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/AdvancedEnzymeT_mojoScore_4233446.png",
        "date": "2026-10-22 10:10:26",
        "description": "Advanced Enzyme Technologies Ltd is rated 'Sell' by MarketsMOJO. This rating was last updated on 25 August 2026, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed below are current as of 22 October 2026, providing investors with the latest perspective on the company’s position."
      },
      {
        "title": "Advanced Enzyme Technologies Ltd Valuation Shifts Signal Elevated Price Risk",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/advanced-enzyme-technologies-ltd-valuation-shifts-signal-elevated-price-risk-4225909",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/AdvancedEnzymeT_valuationdot_4225909.png",
        "date": "2026-10-15 08:00:51",
        "description": "Advanced Enzyme Technologies Ltd has seen a notable shift in its valuation parameters, moving from an expensive to a very expensive rating, despite a modest 0.75% gain in its share price. This change reflects evolving market perceptions and valuation metrics in the Pharmaceuticals & Biotechnology sector, raising questions about price attractiveness relative to historical and peer benchmarks."
      },
      {
        "title": "Advanced Enzyme Technologies Ltd is Rated Sell",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/advanced-enzyme-technologies-ltd-is-rated-sell-4221802",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/AdvancedEnzymeT_mojoScore_4221802.png",
        "date": "2026-10-11 10:10:15",
        "description": "Advanced Enzyme Technologies Ltd is rated 'Sell' by MarketsMOJO. This rating was last updated on 25 August 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 11 October 2026, providing investors with the latest insights into the company’s performance and outlook."
      }
    ],
    "total": 58,
    "sid": "1000007",
    "stock_news_url": "https://researchintel.adityabirlamoney.com/news/advanced-enzyme-technologies-1000007"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Updates on Acquisition",
      "datetime": "19-Nov-2026",
      "details": "Update on acquisition of additional stake of 1.22% in JC Biotech Private Limited Subsidiary i.e. increase in Shareholding from 95.72% to 96.94%",
      "source": "BSE"
    },
    {
      "caption": "Corporate Action-Updates on Buy back",
      "datetime": "05-Nov-2026",
      "details": "Extinguishment of 697582 (Six Lakh Ninety Seven Thousand Five Hundred and Eight Two) fully paid-up Equity Shares of the face value of ? 2/- each (Rupees Two Only) of the Company from the Open Market through the Stock Exchanges",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
      "datetime": "05-Nov-2026",
      "details": "Please find enclosed herewith transcript of earnings call held on November 03 2026 for unaudited financial results for the quarter and half year ended September 30 2026.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Advanced Enzyme Technologies Ltd has declared <strong>67%</strong> dividend, ex-date: 24 Jul 26",
          "dt": "2026-07-24",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Advanced Enzyme Technologies Ltd has announced <strong>2:10</strong> stock split, ex-date: 25 May 17",
          "dt": "2017-05-25",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Updates on Acquisition

19-Nov-2026 | Source : BSE

Update on acquisition of additional stake of 1.22% in JC Biotech Private Limited Subsidiary i.e. increase in Shareholding from 95.72% to 96.94%

Corporate Action-Updates on Buy back

05-Nov-2026 | Source : BSE

Extinguishment of 697582 (Six Lakh Ninety Seven Thousand Five Hundred and Eight Two) fully paid-up Equity Shares of the face value of ? 2/- each (Rupees Two Only) of the Company from the Open Market through the Stock Exchanges

Announcement under Regulation 30 (LODR)-Earnings Call Transcript

05-Nov-2026 | Source : BSE

Please find enclosed herewith transcript of earnings call held on November 03 2026 for unaudited financial results for the quarter and half year ended September 30 2026.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Advanced Enzyme Technologies Ltd has declared 67% dividend, ex-date: 24 Jul 26

stock-summary
SPLITS

Advanced Enzyme Technologies Ltd has announced 2:10 stock split, ex-date: 25 May 17

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available